Assessments of the quality systems of pharmaceutical distributors: a remote approach to be applied in times of COVID-19 and beyond

Figures & data

Fig. 1 Summary of methodology

Table 1 Remote assessment matrix

Table 2 Data collection and analysis tool by distributor

Table 3 Completeness, clarity and accuracy of QA information obtained for GSDP remote assessments across the four distributors

Fig. 2 Overall quality (completeness, clarity, accuracy) of data obtained for the 12 QA activities

Availability of data and materials

Deidentified source data are available in the Study Report, which is provided as Additional file 1.